Vitamin B12 deficiency is a frequently recognized cause of distal symmetric axonal polyneuropathy, and it should be screened for in all patients presenting with polyneuropathy
For B12 to be absorbed properly, it must bind with a protein called "intrinsic factor," which is produced in the stomach
If the answer is "topical only" and the molecule is GHK-Cu, expect surface hydration changes and not much else
The study discussed here was relatively small, involving only 17 patients, and more extensive clinical trials are needed to fully understand: Long-term safety profile Optimal dosing protocols Patient selection criteria Potential side effects Interactions with other treatments Additionally, patients should be aware that BPC-157 is not yet FDA-approved for human use, and treatment is typically offered on a research or compassionate use basis by qualified practitioners
This ensures: Safer treatment Faster symptom relief Optimal nutrient balance Maximum recovery efficiency You get exactly what your body needs, and nothing it doesn't